General Catalyst, the powerhouse venture firm, is considering an IPO, Axios reported Friday morning, citing "multiple sources ...

Sometimes it isn't clear whether a catalyst will be have a positive or negative impact on an asset's price, either in the ...

Baird raised the firm’s price target on Catalyst Pharmaceuticals (CPRX) to $32 from $28 and keeps an Outperform rating on the shares. The firm ...

StockNews.com upgraded shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Friday. Several other research ...

Shares of Catalyst Pharmaceuticals Inc. CPRX rose 5.68% to $22.89 Friday, on what proved to be an all-around great trading ...

Bitcoin and cryptocurrency prices have found a temporary floor following a steep sell-off though analysts have said bitcoin ...

XRP ( XRP 2.06%) is a compelling investment opportunity because it offers investors the chance to get upside from the fees ...

The new GE Aerospace Catalyst turboprop engine has been given the seal of approval by the FAA in a positive sign for ...

Cash burn is likely to moderate going forward, as investments in Schrödinger's internal pipeline have now stabilized. Read ...

A research has developed a method to detect harmful heavy metals through a selective catalytic double metal single atom in ...

BTIG analyst David Larsen lowered the firm’s price target on Health Catalyst (HCAT) to $10 from $13 and keeps a Buy rating on the shares after ...